298 related articles for article (PubMed ID: 22548724)
1. Induction of epithelial-mesenchymal transition by transforming growth factor β.
Moustakas A; Heldin CH
Semin Cancer Biol; 2012 Oct; 22(5-6):446-54. PubMed ID: 22548724
[TBL] [Abstract][Full Text] [Related]
2. Regulation of EMT by TGFβ in cancer.
Heldin CH; Vanlandewijck M; Moustakas A
FEBS Lett; 2012 Jul; 586(14):1959-70. PubMed ID: 22710176
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
4. TGFβ and matrix-regulated epithelial to mesenchymal transition.
Moustakas A; Heldin P
Biochim Biophys Acta; 2014 Aug; 1840(8):2621-34. PubMed ID: 24561266
[TBL] [Abstract][Full Text] [Related]
5. Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144.
Zubeldia IG; Bleau AM; Redrado M; Serrano D; Agliano A; Gil-Puig C; Vidal-Vanaclocha F; Lecanda J; Calvo A
Exp Cell Res; 2013 Feb; 319(3):12-22. PubMed ID: 23153552
[TBL] [Abstract][Full Text] [Related]
6. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
8. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.
Saitoh M
Cancer Sci; 2015 May; 106(5):481-8. PubMed ID: 25664423
[TBL] [Abstract][Full Text] [Related]
10. Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity.
Voon DC; Wang H; Koo JK; Nguyen TA; Hor YT; Chu YS; Ito K; Fukamachi H; Chan SL; Thiery JP; Ito Y
Stem Cells; 2012 Oct; 30(10):2088-99. PubMed ID: 22899304
[TBL] [Abstract][Full Text] [Related]
11. Competitive enhancement of HGF-induced epithelial scattering by accessory growth factors.
Chung JY; Davis JA; Price BD; Staley DM; Wagner MV; Warner SL; Bearss DJ; Hansen MD
Exp Cell Res; 2011 Feb; 317(3):307-18. PubMed ID: 21075102
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-β and miR-24: role in epithelial-to-mesenchymal transition.
Papadimitriou E; Vasilaki E; Vorvis C; Iliopoulos D; Moustakas A; Kardassis D; Stournaras C
Oncogene; 2012 Jun; 31(23):2862-75. PubMed ID: 21986943
[TBL] [Abstract][Full Text] [Related]
13. LIM-domain proteins in transforming growth factor β-induced epithelial-to-mesenchymal transition and myofibroblast differentiation.
Järvinen PM; Laiho M
Cell Signal; 2012 Apr; 24(4):819-25. PubMed ID: 22182513
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of TGFβ-induced lens epithelial to mesenchymal transition (EMT) by RTK antagonists.
Zhao G; Wojciechowski MC; Jee S; Boros J; McAvoy JW; Lovicu FJ
Exp Eye Res; 2015 Mar; 132():9-16. PubMed ID: 25576668
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation.
de Iongh RU; Wederell E; Lovicu FJ; McAvoy JW
Cells Tissues Organs; 2005; 179(1-2):43-55. PubMed ID: 15942192
[TBL] [Abstract][Full Text] [Related]
16. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
[TBL] [Abstract][Full Text] [Related]
17. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
Fuxe J; Karlsson MC
Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional and post-transcriptional regulation in TGF-β-mediated epithelial-mesenchymal transition.
Saitoh M; Miyazawa K
J Biochem; 2012 Jun; 151(6):563-71. PubMed ID: 22528665
[TBL] [Abstract][Full Text] [Related]
19. EMT as the ultimate survival mechanism of cancer cells.
Tiwari N; Gheldof A; Tatari M; Christofori G
Semin Cancer Biol; 2012 Jun; 22(3):194-207. PubMed ID: 22406545
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β.
Tsubakihara Y; Moustakas A
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]